Our HIV response will collapse without US funding - unless we act urgently
|
Nearly eight-million people have HIV in South Africa; they
need life-long antiretroviral medicines to stay healthy. The
near-total removal of US ... |
Gilead's lenacapavir applications for HIV gain EMA validation
Gilead's lenacapavir gained approval in several nations for treating the adult population with multi-drug resistant HIV in conjunction with other ... View article...